Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy. by Bianchi, R, Cervellini, I, Porretta-Serapiglia, C, Oggioni, N, Burkey, B, Ghezzi, P, Cavaletti, G, Lauria, G

CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats by Meregalli C, Ceresa C, Canta A, Carozzi VA, Chiorazzi A, Sala B, Oggioni N, Lanza M, Letari O, Ferrari F, Avezza F, Marmiroli P, Caselli GF, Cavaletti G

Get full text

Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies. by Chiorazzi, A, Nicolini, G, Canta, A, Oggioni, N, Rigolio, R, Cossa, G, Lombardi, R, Roglio, I, Cervellini, I, Lauria, G, Melcangi, R, Bianchi, R, Crippa, D, Cavaletti, G

Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy. by Meregalli, C, Chiorazzi, A, Carozzi, V, Canta, A, Sala, B, Colombo, M, Oggioni, N, Ceresa, C, Foudah, D, La Russa, F, Miloso, M, Nicolini, G, Marmiroli, P, Bennett, D, Cavaletti, G

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats. by Cervellini, I, Bello, E, Frapolli, R, Porretta-Serapiglia, C, Oggioni, N, Canta, A, Lombardi, R, Camozzi, F, Roglio, I, Melcangi, R, D'incalci, M, Lauria, G, Ghezzi, P, Cavaletti, G, Bianchi, R